The role of IFI35 in lupus nephritis and related mechanisms

References

• Li Y, Fang X, Li QZ. Biomarker profiling for lupus nephritis. Genom Proteom Bioinform. 2013;11:158–65.
   PubMedGoogle Scholar
• Haas C, Ryffel B, Le Hir M. IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice. J Immunol. 1997;158:5484–91.
   PubMed Web of Science ®Google Scholar
• Nicoletti F, Di Marco R, Zaccone P, Xiang M, Magro G, Grasso S, et al. Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus-like syndrome in MRL-lpr/lpr mice. Eur J Immunol. 2000;30:438–47.
   PubMed Web of Science ®Google Scholar
• de Prati AC, Ciampa AR, Cavalieri E, Zaffini R, Darra E, Menegazzi M, et al. STAT1 as a new molecular target of anti-inflammatory treatment. Curr Med Chem. 2005;12:1819–28.
   PubMed Web of Science ®Google Scholar
• Schwarting A, Wada T, Kinoshita K, Tesch G, and Kelley VR. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice. J Immunol. 1998;161:494–503.
   PubMed Web of Science ®Google Scholar
• Shao WH, Gamero AM, Zhen Y, Lobue MJ, Priest SO, Albandar HJ, et al. Stat1 regulates lupus-like chronic graft-versus-host disease severity via interactions with Stat3. J Immunol. 2015;195:4136–43.
   PubMed Web of Science ®Google Scholar
• Bange FC, Vogel U, Flohr T, Kiekenbeck M, Denecke B, and Bottger EC. IFP 35 is an interferon-induced leucine zipper protein that undergoes interferon-regulated cellular redistribution. J Biol Chem. 1994;269:1091–8.
   PubMed Web of Science ®Google Scholar
• Yang W, Tan J, Liu R, Cui X, Ma Q, Geng Y, et al. Interferon-gamma upregulates expression of IFP35 gene in HeLa cells via interferon regulatory factor-1. PLoS One. 2012;7:e50932.
   PubMed Web of Science ®Google Scholar
• Arasappan D, Tong W, Mummaneni P, Fang H, and Amur S. Meta-analysis of microarray data using a pathway-based approach identifies a 37-gene expression signature for systemic lupus erythematosus in human peripheral blood mononuclear cells. BMC Med. 2011;9:65.
   PubMed Web of Science ®Google Scholar
• Coit P, Renauer P, Jeffries MA, Merrill JT, McCune WJ, Maksimowicz-McKinnon K, et al. Renal involvement in lupus is characterized by unique DNA methylation changes in naive CD4+ T cells. J Autoimmun. 2015;61:29–35.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhao M, Sawalha AH, Richardson B, and Lu Q. Impaired DNA methylation and its mechanisms in CD4(+)T cells of systemic lupus erythematosus. J Autoimmun. 2013;41:92–9.
   PubMed Web of Science ®Google Scholar
• Balada E, Castro-Marrero J, Felip L, Ordi-Ros J, and Vilardell-Tarres M. Associations between the expression of epigenetically regulated genes and the expression of DNMTs and MBDs in systemic lupus erythematosus. PLoS One. 2012;7:e45897.
   PubMed Web of Science ®Google Scholar
• Reilly CM, Oates JC, Cook JA, Morrow JD, Halushka PV, and Gilkeson GS. Inhibition of mesangial cell nitric oxide in MRL/lpr mice by prostaglandin J2 and proliferator activation receptor-gamma agonists. J Immunol. 2000;164:1498–504.
   PubMed Web of Science ®Google Scholar
• Zhu H, Mi W, Luo H, Chen T, Liu S, Raman I, et al. Whole-genome transcription and DNA methylation analysis of peripheral blood mononuclear cells identified aberrant gene regulation pathways in systemic lupus erythematosus. Arthritis Res Ther. 2016;18:162.
   PubMed Web of Science ®Google Scholar
• Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271–7.
   PubMed Web of Science ®Google Scholar
• AT M. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980;23:581–90.
   PubMedGoogle Scholar
• Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580–8.
   PubMed Web of Science ®Google Scholar
• Kubben FJ, Peeters-Haesevoets A, Engels LG, Baeten CG, Schutte B, Arends JW, et al. Proliferating cell nuclear antigen (PCNA): a new marker to study human colonic cell proliferation. Gut. 1994;35:530–5.
   PubMed Web of Science ®Google Scholar
• Patel K, Harding P, Haney LB, Glass WF II. Regulation of the mesangial cell myofibroblast phenotype by actin polymerization. J Cell Physiol. 2003;195:435–45.
   PubMed Web of Science ®Google Scholar
• Delmas Y, Viallard JF, Solanilla A, Villeneuve J, Pasquet JM, Belloc F, et al. Activation of mesangial cells by platelets in systemic lupus erythematosus via a CD154-dependent induction of CD40. Kidney Int. 2005;68:2068–78.
   PubMed Web of Science ®Google Scholar
• Al-Janadi M, al-Balla S, al-Dalaan A, Raziuddin S. Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases. J Clin Immunol. 1993;13:58–67.
   PubMed Web of Science ®Google Scholar
• Funauchi M, Sugishima H, Minoda M, and Horiuchi A. Serum level of interferon-gamma in autoimmune diseases. Tohoku J Exp Med. 1991;164:259–67.
   PubMed Web of Science ®Google Scholar
• Masutani K, Akahoshi M, Tsuruya K, Tokumoto M, Ninomiya T, Kohsaka T, et al. Predominance of Th1 immune response in diffuse proliferative lupus nephritis. Arthritis Rheum. 2001;44:2097–106.
   PubMed Web of Science ®Google Scholar
• Haas C, Ryffel B, and Le Hir M. IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW)F1 mice. J Immunol. 1998;160:3713–8.
   PubMed Web of Science ®Google Scholar
• Balomenos D, Rumold R, and Theofilopoulos AN. Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J Clin Invest. 1998;101:364–71.
   PubMed Web of Science ®Google Scholar
• Miyake K, Nakashima H, Akahoshi M, Inoue Y, Nagano S, Tanaka Y, et al. Genetically determined interferon-gamma production influences the histological phenotype of lupus nephritis. Rheumatology. 2002;41:518–24.
   PubMed Web of Science ®Google Scholar
• Wang X, Johansen LM, Tae HJ, and Taparowsky EJ. IFP 35 forms complexes with B-ATF, a member of the AP1 family of transcription factors. Biochem Biophys Res Commun. 1996;229:316–22.
   PubMed Web of Science ®Google Scholar
• Shaulian E, and Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol. 2002;4:E131–6.
   PubMed Web of Science ®Google Scholar
• Balada E, Ordi-Ros J, Serrano-Acedo S, Martinez-Lostao L, and Vilardell-Tarres M. Transcript overexpression of the MBD2 and MBD4 genes in CD4+ T cells from systemic lupus erythematosus patients. J Leukoc Biol. 2007;81:1609–16.
   PubMed Web of Science ®Google Scholar
• Berger J, Bird A. Role of MBD2 in gene regulation and tumorigenesis. Biochem Soc Trans. 2005;33:1537–40.
   PubMed Web of Science ®Google Scholar
• Vallin H, Blomberg S, Alm GV, Cederblad B, and Ronnblom L. Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-alpha (IFN-alpha) production acting on leucocytes resembling immature dendritic cells. Clin Exp Immunol. 1999;115:196–202.
   PubMed Web of Science ®Google Scholar
• McInnes IB, and Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 2007;7:429–42.
   PubMed Web of Science ®Google Scholar
• Canete JD, Martinez SE, Farres J, Sanmarti R, Blay M, Gomez A, et al. Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies. Ann Rheum Dis. 2000;59:263–8.
   PubMed Web of Science ®Google Scholar
• Dantas AT, G SMC, Pereira MC, Almeida AR, Marques CDL, Rego MJBDM, Pitta IDR, et al. AB0058 interferons and systemic sclerosis: correlation between interferon gamma and interferon-lambda 1 (IL-29). Ann Rheum Dis. 2015;74:910.
   Web of Science ®Google Scholar